Tech Company Financing Transactions

Xcell Biosciences Funding Round

Casdin Capital, Dynamk Capital and Formic Ventures participated in a $27.5 million Series B funding round for Xcell Biosciences. The funding round was announced on 1/29/2022.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

455 Mission Bay Blvd. South
San Francisco, CA 94158
USA

Phone

(415) 937-0321

Website

www.xcellbio.com

Email Address

[email protected]

Overview

Xcell Biosciences, Inc., is developing revolutionary products and workflows that empower scientists in important fields including cancer research, immunology, stem cell biology, and cell therapy development.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Brian Feth

        

Chief Operating Officer

Janette Phi

        

Chief Scientific Officer

James Lim

        

Browse more venture capital transactions:

Prev: 1/29/2022: Casana venture capital transaction
Next: 1/29/2022: Vinter venture capital transaction

Share this article

Where The Data Comes From

We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary